The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Topics, Trends & Updates for August (8/3/21)
- Medscape Interviews Dr. Elliot DeHaan, Lead Author of New Guideline on CAB/RPV LA (8/3/21)
- Medscape Commentary: IRIS: 'Why Is My Patient Getting Worse?' (7/29/21)
- Updated Resource: ART Drug-Drug Interactions (7/20/21)
- Updated Guideline: Diagnosis and Management of Acute HIV Infection (7/20/21)
- New Guideline: Substance Use Disorder Treatment in Pregnant Adults (7/16/21)
- New Guideline: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (7/14/21)
- New Recommendation: COVID-19 Vaccine for Adults With HIV (7/13/21)
- CEI Newsletter (9/21/21)
- PrEP Aware Week -- Save the Dates: October 25 to 31 (9/17/20)
- AETC NCRC: Quarterly Newsletter (9/13/21)
- HIVinfo Updated Fact Sheets on HIV and Pregnancy (9/9/21)
- NYS Medicaid Update (9/9/21)
- NYSDOH Health Advisory: Increased Number of HIV Diagnoses in Erie and Monroe Counties (8/30/17)
- Q/A: Why Are Vaccines and Masks Needed for Protection During the COVID-19 Pandemic? (8/17/21)
- New Recommendation: COVID-19 Vaccine for Adults With HIV (7/13/21)
- NYC Health: FAQ About COVID-19 for Health Care Providers (3/24/21)
- NYCDOHMH: Dear Colleague COVID-19 Updates, Building Confidence in COVID-19 Vaccines and Vaccination (3/2/21)
- DHHS Interim Guidance for COVID-19 and Persons with HIV (3/1/21)
- CDC: COVID-19 and HIV (3/1/21)
- Medical Care Criteria Committee Advocates COVID-19 Vaccine Priority Status for People With HIV (1/12/21)
- Guidance: Opioid Use Disorder Treatment During COVID-19 (1/4/21)
- FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations (9/22/21)
- FDA Approves First COVID-19 Vaccine (8/23/21)
- NYCDOHMH: COVID-19 Monoclonal Antibody Treatment Updates for the Outpatient Setting (8/21/21)
- NYCDOHMH: COVID-19 Vaccine Update: Additional mRNA Dose for People Who Are Immunocompromised (8/17/20)
- aidsmap: COVID-19 Vaccines Produce Strong Antibody Responses in People With HIV After Two Doses (8/5/21)
- NYCDOHMH: Guillain-Barre Syndrome After J&J COVID-19 Vaccine and Additional Doses (8/3/21)